Treatment sequencing and flexible dosing in later-line management of CRC
Treatment sequencing and flexible dosing in later-line management of CRC
Assoc. Prof. Gerald Prager, Prof. Chiara Cremolini
Prof. Heinz-Josef Lenz led an interesting Experts Knowledge Share on the topic ‘Treatment sequencing and flexible dosing in later-line management of colorectal cancer’ with Dr Chiara Cremolini and Dr Gerald Prager providing opposing perspectives.
Assoc. Prof. Gerald Prager
Medical Oncologist
Medical University of Vienna
Austria
Dr Gerald Prager is an Associate Professor of Medicine, Board Certified for Internal Medicine Board and Certified for Haematology and Medical Oncology. In 2009, he received his M.D. from the University of Vienna. Currently, Dr Prager is Director of the Colorectal Cancer Unit of the Department of Medical Oncology at the Medical University of Vienna. He is also a member of the ESMO 2014 Scientific Committee. The research interest of his lab focuses on (tumour-) angiogenesis via regulation of endothelial cell survival and migration by cell / extracellular-matrix interaction. Through his clinical training in haemato-oncology, he became a member of the sought-after group of medical researches. He achieved his expertise in international renowned labs at University of California, San Diego, the Norris Cancer Center, Los Angeles and the Department of Vascular Biology, Mississippi University for Women (MUW). His work is honoured by 19 international awards and resulted in publications in international highly renowned journals. Dr Prager’s young research group is embedded in an international cancer research campus associated with Medical University of Vienna (MUV).
Assoc. Prof. Gerald Prager has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Amgen, AstraZeneca, Bayer, BMS, Incyte, Merck Serono, MSD, Servier, Takeda
Prof. Chiara Cremolini
Medical Oncologist
Pisa University Hospital
Italy
Dr Chiara Cremolini is a Medical Oncologist at Santa Chiara University Hospital in Pisa, Italy. Chiara completed her M.D. Degree in 2008, and gained an M.Sc. in Clinical Trials in 2011, and the Specialty in Medical Oncology in 2014 at the University of Pisa. She is mainly committed to the clinical management of patients affected by gastrointestinal malignancies and is involved in clinical and translational research projects in the field of colorectal oncology. She actively contributes to clinical trials by the cooperative Gruppo Oncologico Nord Ovest (GONO) group and is interested in the identification of molecular predictors of benefit from systemic treatments. Chiara is co-author of about 60 peer-reviewed papers and received merit awards at the following meetings: American Society of Clinical Oncology (ASCO) 2010, 2012−2015; European Society for Medical Oncology (ESMO) 2011 and 2014; European CanCer Organisation (ECCO) 2013.
Prof. Chiara Cremolini has no relevant financial relationships to disclose.
|
5 min
|
Sep 2021
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
download resources
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
Prof. Heinz-Josef Lenz led an interesting Experts Knowledge Share on the topic ‘Treatment sequencing and flexible dosing in later-line management of colorectal cancer’ with Dr. Chiara Cremolini and Dr. Gerald Prager providing opposing perspectives. Please note that the views presented do not reflect the Experts’ own opinions but are intended to represent opposing perspectives on the topic of discussion. Please click on the link to watch the video and download the slides.
GI CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer.